Abstract
Deposition of aggregated amyloid β-protein (Aβ), a proteolytic cleavage product of the amyloid precursor protein (APP), is a fundamental pathological event in the development of Alzheimer’s disease (AD) [1]. Although a great deal of effort has been made to clarify the pathogenesis of AD, we are still far from a complete understanding of the molecular mechanism underlying the initiation of amyloid fibril formation. In regard to the mechanism of protein aggregation, the nucleation-dependent polymerization theory is widely accepted [2]. In this model, a long lag-time is required for nucleation. Furthermore, the concentration of a given protein is required to be greater than a critical level for nucleation. In regard to the polymerization of Aβ in vitro,Aβ at concentrations below 20 μM is unlikely to aggregate spontaneously. Considering that the physiological concentration of Aβ in biological fluids, including the cerebrospinal fluid, sera and culture media, is as low as 10 nM, even in the case of the expression of some genes responsible for familial AD which could induce increased generation of Aβ [3–6], one would assume that Aβ probably aggregates in brains in the presence of pathological chaperones such as apolipoprotein E4, α1-antichymotrypsin and proteoglycans. Alternatively, a pathological Aβ species with the ability to act as a seed or a template for fibril formation could be generated via a conformational alteration of Aβ, as has been postulated for the development of prion diseases [7]. In this chapter, I describe two novel Aβspecies with seeding ability, which were identified in the brains with AD or in culture media in our studies [8–10].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Selkoe DJ (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer’s disease. Annu Rev Cell Biol 10: 373–403
Jarrett JT, Lansbury PT Jr (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73: 1055–1058
Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer’s disease increases β-protein production. Nature 360: 672–674
Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514–516
Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloidβ protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264: 1336–1340
Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W et al (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2: 864–870
Prusiner SB (1997) Prion diseases and the BSE crisis. Science 278: 245–251
Yanagisawa K, Odaka A, Suzuki N, Ihara Y (1995) GM1 ganglioside-bound amyloid β-protein (Aβ): A possible form of preamyloid in Alzheimer’s disease. Nat Med 1: 1062–1066
Mizuno T, Haass C, Michikawa M, Yanagisawa K (1998) Cholesterol-dependent generation of a unique amyloid β-protein from apically missorted amyloid precursor protein in MDCK cells. Biochim Biophys Acta 1373: 119–130
Mizuno T, Nakata M, Naiki H, Michikwa M, Wang R, Haass C, Yanagisawa K (1999) Cholesterol-dependent generation of a seeding amyloidβ-protein in cell culture. J Biol Chem 274: 15110–15114
McLaurin J, Chakrabartty A (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J Biol Chem 271: 26482–26489
Choo-Smith LP, Surewicz WK (1997) The interaction between Alzheimer amyloid β (1–40) peptide and ganglioside GM1-containing membranes. FEBS Lett 402: 95–98
Matsuzaki K, Horikiri C (1999) Interactions of amyloid β-peptide (1–40) with ganglioside-containing membranes. Biochemistry 38: 4137–4142
Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK (1997) Acceleration of amyloid fibril formation by specific binding of Aβ (1–40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 272: 22987–22990
Haass C, Koo EH, Capell A, Teplow DB, Selkoe DJ (1995) Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol 128: 537–547
Haass C, Koo EH, Teplow DB, Selkoe DJ (1994) Polarized secretion of β-amyloid precursor protein and amyloid β-peptide in MDCK cells. Proc Nati Acad Sci USA 91: 1564–1568
Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387: 569–572
Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT Jr, Kosik KS (1998) A detergent-insoluble membrane compartment contains Aβ in vivo. Nat Med 4: 730–734
Morishima-Kawashima M, Ihara Y (1998) The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37: 15247–15253
Igbavboa U, Avdulov NA, Schroeder F, Wood WG (1996) Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J Neurochem 66: 1717–1725
Igbavboa U, Avdulov NA, Chochina SV, Wood WG (1997) Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J Neurochem 69: 1661–1667
van Helvoort A, van Meer G (1995) Intracellular lipid heterogeneity caused by topology of synthesis and specificity in transport. Example: sphingolipids. FEBS Lett 369: 18–21
Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB, Avraham D (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform [published erratum appears in. J Cell Biol 1995, 30(2): 501]. J Cell Biol 129: 121–132
Naslaysky N, Stein R, Yanai A, Friedlander G, Taraboulos A (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272: 6324–6331
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Basel AG
About this paper
Cite this paper
Yanagisawa, K. (2001). Molecular mechanisms underlying initiation of amyloid fibril formation. In: Tanaka, C., McGeer, P.L., Ihara, Y. (eds) Neuroscientific Basis of Dementia. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8225-5_29
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8225-5_29
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9482-1
Online ISBN: 978-3-0348-8225-5
eBook Packages: Springer Book Archive